Mahindra and Mahindra and Manulife life insurance JV announce MD and CEO designate

Suresh Agarwal appointed as the MD & CEO designate of its proposed life insurance JV, subject to regulatory approvals

by e4m Staff
Published: Feb 26, 2026 10:37 AM | 1 min read

Mahindra & Mahindra Ltd. (M&M) and Manulife have appointed Suresh Agarwal as the MD & CEO designate of their proposed life insurance joint venture, pending regulatory approvals.
The joint venture, established as a 50:50 partnership, was announced in November 2022 and aims to enhance financial wellbeing in a rapidly growing life insurance market.
Suresh Agarwal brings nearly 30 years of experience in life and general insurance, as well as corporate and retail lending.
He has a proven track record in driving growth, implementing transformative strategies, and developing high-margin business models across various channels.

Mahindra & Mahindra Ltd. (M&M) and Manulife announced the appointment of Suresh Agarwal as the MD & CEO designate of its proposed life insurance JV, subject to regulatory approvals. The agreement to establish a 50:50 life insurance JV was announced in November last year, underscoring the two companies’ commitment to enhancing the financial wellbeing of customers in one of the world's fastest-growing life insurance markets.

Agarwal has nearly 30 years of experience in life and general insurance, corporate, and retail lending. He spearheaded growth, executed transformative strategies, and built high-margin business models across multiple channels. Agarwal has spent significant